Skybiotech Healthcare Limited

Skybiotech Healthcare Limited, a micro-cap textile manufacturer with a market capitalisation of ₹28.00 crores, reported a net loss of ₹0.30 crores for Q4 FY26, marking the seventh consecutive quarter of losses despite a sharp revenue uptick. The stock surged 5.00% on June 01, 2026, closing at ₹152.25, though this represents a 35.84% decline from its 52-week high of ₹237.30.

Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Kapil Cotex Ltd, a player in the Garments & Apparels sector, recorded a fresh 52-week low of Rs.116.45 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics.

Kapil Cotex Ltd, a player in the Garments & Apparels sector, has recorded a fresh 52-week low of Rs.126.45 today, marking a significant decline amid persistent downward momentum. The stock’s recent performance reflects ongoing pressures that have weighed on its valuation and market standing.

Skybiotech Healthcare Limited reported a net loss of ₹0.48 crores for Q3 FY26 (Oct-Dec'25), marking a sequential deterioration of 54.84% from Q2 FY26's loss of ₹0.31 crores. The micro-cap garments and apparels company, with a market capitalisation of just ₹27.00 crores, continues to struggle with operational inefficiencies as revenue collapsed 50.00% quarter-on-quarter to ₹0.96 crores. The stock traded at ₹144.90 on February 16, 2026, down 35.54% over the past year, reflecting persistent investor concerns about the company's viability.

Kapil Cotex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 December 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 February 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Kapil Cotex Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 December 2025, providing investors with the most up-to-date view of the company's performance and outlook.

Kapil Cotex, a player in the Garments & Apparels sector, is currently navigating a complex market environment marked by subdued financial performance and shifting technical indicators. Recent assessment changes reflect a cautious market stance as the company’s stock price trends lower amid broader sector challenges and internal operational factors.

Kapil Cotex, a microcap player in the Garments & Apparels sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The recent assessment highlights concerns across quality, valuation, financial trends, and technical outlook, signalling a cautious stance for investors.

Kapil Cotex Ltd has encountered severe selling pressure on 2 December 2025, with the stock hitting the lower circuit and registering only sell orders in the queue. This unusual trading pattern signals distress selling and a lack of buyer interest, raising concerns about the stock’s near-term outlook within the Garments & Apparels sector.

Kapil Cotex Ltd, a key player in the Garments & Apparels sector, is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers. This distress selling signals a challenging phase for the company as it faces consecutive losses and a notable underperformance relative to market benchmarks.

Kapil Cotex Ltd is currently experiencing severe selling pressure, with the stock hitting the lower circuit and registering only sell orders in the queue. This unusual trading pattern signals distress selling and a lack of buyer interest, raising concerns about the stock’s near-term outlook within the Garments & Apparels sector.

Kapil Cotex Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the order book. This extreme selling activity signals distress among investors, as the company’s shares continue to reflect consecutive losses over multiple time frames, contrasting sharply with broader market gains.